References
- Hashem AEA, Mostafa GMH, El-Faramawy MSM. Red blood cell alloantibodies in healthy Egyptian blood donors. Egyptian J Hospital Med 2018;72:4913–8.
- Strobel E. Hemolytic transfusion reactions. Transfus Med Hemother 2008;35:346–53.
- Canadian Blood Services. Clinical guide to transfusion. Version 4.0. Ottawa: Canadian Blood Services, 2019.
- Joint United Kingdom Blood Transfusion and Tissue Transplantation Services (JPAC). Mandatory testing of blood donations. Available from https://www.transfusionguidelines.org/red-book/chapter-12-donation-testing-red-cell-immunohaematology/12-10-mandatory-testing-of-blood-donations. Accessed 5 August 2025.
- Franchini M, Forni GL, Marano G, et al. Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review. Blood Transfus 2019;17:4–15.
- Yadav A, Raturi G, Aparna B. Prevalence of irregular red cell antibody in transfusion recipients vis-a-vis healthy blood donors attending a tertiary care hospital in north India. Asian J Transfus Sci 2022;16:73–7.
- Nathani KJ, Patel J, Modi P, et al. Prevalence of red cell alloantibodies & autoantibodies in patient & donor attending a tertiary care hospital in south Gujarat. Int J Contemp Med Res 2021;8:C1–5.
- Makroo RN, Rajput S, Agarwal S, et al. Prevalence of irregular red cell antibodies in healthy blood donors attending a tertiary care hospital in South India. Asian J Transfus Sci 2018;12: 17–20.
- Rolon TME, Hoyos GK, Correa OA, et al. Blood donors characterization with positive irregular antibodies in Montería, Colombia, 2012–2015. Rev Cubana Hematol Inmunol Hemoter 2019;35:1–12.
- Solanki A, Chandra T, Singh A. Prevalence of red blood cell antibodies in whole blood donors: a single-centre experience in north India. Indian J Med Res 2020;152:280–4.
- Karafin MS, Tan A, Tormey CA, et al. Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Transfusion 2019;59:217–25.
- Tiwari AK, Pandey P, Sharma J, et al. Incidence of clinically significant antibodies in patients and healthy blood donors: a prospective cross-sectional study from a tertiary healthcare center in India. Transfus Apher Sci 2014;50:230–4.
- Hendrickson JE, Tormey CA. Understanding red blood cell alloimmunization triggers. Hematology 2016;1:446–51.
- García MA, Bautista L, Palomino F. Should blood donors be routinely screened for irregular antibodies? Immunohematology 2012;28:60–6.
- National Institute of Hematology and Blood Transfusion, Vietnam. Central Institute of Hematology and Blood Transfusion. Available from https://vienhuyethoc.vn/nhommau-va-nhom-mau-hiem/. Accessed 5 August 2025.
- Nguyen TTT, Nguyen THH, Đong SS, et al. Survey on the rate of the ABO and Rh(D) blood group systems of volunteer blood donors at Hue Blood Transfusion Center. Ho Chi Minh City J Med 2015;19:433.
- Sivakaanthan A, Hollands S, Powley T, et al. Routine donor red cell antibody screening: considering the alternate strategy. Vox Sang 2022;117:708–14.
- Promwong C, Siammai S, Hassarin S, et al. Frequencies and specificities of red cell alloantibodies in the southern Thai population. Asian J Transfus Sci 2013;7:16–20.
- Solanki A, Chaudhary RK, Sonker A, et al. Frequency and characterization of irregular red cell antibodies among blood donors in a tertiary care hospital in north India. Indian J Med Res 2020;152:632–8.
- Choi HW, Kim S, Lee K, et al. Naturally occurring anti-Mi(a) detected in a young male patient. Ann Lab Med 2004;24: 202–4.
- Nguyen TQ, Do TT, Hoang NTT, et al. Frequencies of different blood group antigens and phenotypes in northern Vietnamese donors. Transfus Med 2025;35:346–51.
- Cohn CS, Delaney M, Johnson ST, et al. AABB technical manual. 21st ed. Bethesda, MD: AABB, 2023:358.